Reticular erythematous mucinosis

From WikiMD's WELLNESSPEDIA

(Redirected from REM syndrome)

Reticular erythematous mucinosis
Synonyms REM syndrome
Pronounce N/A
Specialty N/A
Symptoms N/A
Complications N/A
Onset N/A
Duration N/A
Types N/A
Causes N/A
Risks N/A
Diagnosis N/A
Differential diagnosis N/A
Prevention N/A
Treatment N/A
Medication N/A
Prognosis N/A
Frequency N/A
Deaths N/A


Reticular erythematous mucinosis (REM) is a rare skin condition characterized by a reticular (net-like) pattern of erythematous (red) patches. It is primarily seen in middle-aged women and is associated with the accumulation of mucin in the dermis.

Presentation[edit]

Patients with reticular erythematous mucinosis typically present with red, net-like patches on the chest and back. These patches may be asymptomatic or associated with mild itching. The condition is chronic and may persist for many years.

Pathophysiology[edit]

The exact cause of reticular erythematous mucinosis is unknown. It is thought to be related to hormonal changes, as it predominantly affects women. The condition is characterized by the deposition of mucin in the dermis, which is a gel-like substance that can accumulate in the skin.

Diagnosis[edit]

Diagnosis of reticular erythematous mucinosis is primarily clinical, supported by a skin biopsy. The biopsy typically shows mucin deposition in the dermis and a mild perivascular lymphocytic infiltrate.

Treatment[edit]

Treatment options for reticular erythematous mucinosis include topical corticosteroids, antimalarials such as hydroxychloroquine, and phototherapy. The response to treatment can vary, and some patients may experience spontaneous resolution of the condition.

Prognosis[edit]

The prognosis for reticular erythematous mucinosis is generally good, although the condition can be persistent. It is not associated with any serious systemic complications.

See also[edit]

References[edit]


External links[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.